South Korea · Delayed Price · Currency is KRW Daewoong Pharmaceutical Company Description
Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins.
The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices.
The company was founded in 1945 and is headquartered in Seoul, South Korea.develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins.
The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices.
The company was founded in 1945 and is headquartered in Seoul, South Korea.develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins.
The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices.
Daewoong Pharmaceutical Co., Ltd. has a collaboration agreement with Salipro Biotech AB for the use of Salipro platform for stabilizing challenging membrane proteins to advance drug discovery.
The company was founded in 1945 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1945 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,644 |
Contact Details
Address: 12, Bongeunsa-ro 114-gil Seoul, 135-715 South Korea | |
| Phone | 82 2 550 8209 |
| Website | daewoong.com |
Stock Details
| Ticker Symbol | 069620 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7069620003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Seongsoo Park | Chief Executive Officer and Executive Director |
| Chang-Jae Lee | Chief Executive Officer and Executive Director |
| Eunkyeong Park | Executive Director |